Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Catalin Toma Added: 1 week ago
Dr Catalin Toma joins us to share practical guidance on catheter-based intervention for pulmonary embolism, offering clinical insights for interventionalists navigating this increasingly active space.As catheter-directed therapies for PE continue to evolve and expand into more centres, questions around patient selection, technique, and post-procedural management remain front of mind for the… View more
Author(s): Frederick Welt Added: 8 months ago
Learn about the definition and implications of a shock diagnosis and systems of care and the role of the shock team from Dr Frederick Welt (University of Utah, US).This three-part video lecture series, part of Women As One’s CLIMB® 2025 Skills Training Programme, offers case-based insights into Coronary and Mechanical Support for Cardiogenic Shock, curated by Dr Alison Duncan and Dr Frederick… View more
Author(s): Daniel Clair Added: 1 year ago
ISET 2025 - Safety and efficacy outcomes of an intravascular lithotripsy (IVL) catheter used for the treatment of moderate to severely calcified lesions show a high ability to deliver the catheter with access to the lesion and very low rates of myocardial infarction and distal embolisation.Dr Daniel Clair (Vanderbilt University Medical Center, TN, US) joins us to discuss the key findings from the… View more
Author(s): Stavros Konstantinides, Sylwia Sławek-Szmyt, José M Montero-Cabezas ,et al Start date: Dec 04, 2025
STORM-PE: Novel Data Driving Change in PE TreatmentJoin us for an exclusive webinar chaired by Prof Konstantinides (Mainz, DE), offering a focused exploration of advanced treatment strategies for intermediate-high and high-risk pulmonary embolism (PE). Together with leading experts Dr Montero-Cabezas (Leiden, NL), Dr Iannaccone (Turin, IT) and Dr Sławek-Szmyt (Poznan, PL), this session will… View more
Author(s): Marianne Brodmann Added: 1 year ago
LINC 2025 - 12-month amputation and readmission rates from the TRUE-PTX study suggests endovascular revascularisation for peripheral artery disease (PAD) with drug-eluting devices lead to better outcomes than with bare device therapies.Dr Marianne Brodmann (Medical University of Graz, AT) joins us to discuss the TRUE-PTX study evaluating a database of patients in the US with PAD who have recieved… View more